Jazz Pharmaceuticals

Healthcare 📍 Palo Alto, United States 👥 1-10 employees 💰 $377.0M raised 📅 Founded 2003

Jazz Pharmaceuticals, Inc. focuses on identifying, developing, and commercializing products for neurology and psychiatry primarily in the United States. Its products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Cystadane for the treatment of homocystinuria,

🌐 Website ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

1-10

Total Raised · Debt

$377.0M

Founded

2003

Cloud

Unknown

Email

Proofpoint

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Proofpoint
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$18K – $45K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Jazz Pharmaceuticals's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction